Pediatric parvovirus B19: spectrum of clinical manifestations

Monica N Valentin1, Philip J Cohen

  • 1Department of Dermatology, New Jersey Medical School, 185 South Orange Ave, Room H-576, Newark, NJ 07103-2714, USA. Philip.Cohen@va.gov.

Cutis
|November 7, 2013
PubMed

Insights

Parvovirus B19 infection presents with diverse symptoms, most commonly erythema infectiosum in children. High-risk groups face severe hematologic issues, necessitating clinical diagnosis and symptomatic treatment.

Area of Science:

  • Virology and Pediatric Infectious Diseases

Background:

  • Parvovirus B19 (PVB19) infection exhibits a wide range of clinical presentations, from asymptomatic cases to severe hematologic complications.
  • Erythema infectiosum (EI), or fifth disease, is the most frequent manifestation in children, characterized by a distinctive facial rash.
  • While typically self-limiting in healthy children, PVB19 infection poses significant risks to immunocompromised individuals, those with hemolytic anemia, or prenatally exposed infants.

Purpose of the Study:

  • To review the clinical spectrum of Parvovirus B19 infection.
  • To highlight diagnostic approaches and management strategies for PVB19.
  • To discuss the implications of PVB19 in different pediatric populations.

Main Methods:

  • Clinical review of Parvovirus B19 infection manifestations.
  • Summary of diagnostic criteria, including clinical presentation and serologic testing.
  • Overview of current treatment approaches and future vaccine development.

Main Results:

  • Parvovirus B19 infection causes varied symptoms, with erythema infectiosum being common in children.
  • Diagnosis is primarily clinical, supported by serologic tests.
  • High-risk pediatric groups experience more severe, hematologic manifestations.

Conclusions:

  • Parvovirus B19 infection requires careful management, especially in vulnerable pediatric populations.
  • Symptomatic treatment is the current standard of care.
  • Ongoing research aims to develop a vaccine for PVB19.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
219
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
108
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
59
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
95
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
32
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64